Independent
Tenure on this board
12.3 yrs
Also a director at
Veracyte Inc (VCYT)
3 nominees · 4 ballot items.
Election of three Class I directors; Ratification of Ernst & Young LLP as independent auditors; Non-binding advisory approval of named executive officer compensation; Approval to amend and restate 2022 Stock Option and Incentive Plan to increase share reserve by 7,000,000 shares.
Election of three Class I directors (Robert S. Epstein, Karin Jooss, and Laura J. Hamill) to serve until the 2029 Annual Meeting.
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2026.
Conduct a non-binding advisory (say-on-pay) vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
Approve the third amendment and restatement of the 2022 Plan to increase the number of shares reserved for issuance under the plan by 7,000,000 shares (from 24,500,000 to 31,500,000).
The Board proposes an amendment and restatement of the 2022 Stock Option and Incentive Plan to add 7,000,000 shares to the plan reserve, increasing it to 31,500,000 shares. Management seeks approval to ensure sufficient shares for equity awards to attract, retain, and motivate employees, directors and consultants given competitive labor markets and the Company’s hiring and retention needs. The filing explains the Company’s historical and projected burn rates, the overhang relative to peers, and Aon’s analysis supporting the requested increase. The proposal would not add an evergreen feature and contains governance protections including no single-trigger acceleration on a sale event unless awards are not assumed, no repricing without stockholder approval, and director compensation limits. Failure to approve would leave the Company with its existing share reserve and could limit its ability to grant equity awards, potentially prompting increased cash compensation or alternative arrangements. The Board recommends a shareholder vote FOR this proposal as necessary to preserve the Company’s ability to implement its compensation strategy and maintain competitive positioning.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Redmile Group, LLC | 11.04% | 12,872,946 | $15M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.60% | 4,192,063 | $5M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.55% | 4,134,585 | $5M |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 3.53% | 4,120,200 | $5M |
| 5 | BlackRock, Inc. | 3.47% | 4,048,767 | $5M |
| 6 | BlackRock, Inc. | 3.36% | 3,915,865 | $5M |
| 7 | TWO SIGMA INVESTMENTS, LP | 2.97% | 3,466,786 | $4M |
| 8 | JOHNSON JOHNSON | 2.90% | 3,379,064 | $4M |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2.55% | 2,974,683 | $4M |
| 10 | AQR CAPITAL MANAGEMENT LLC | 2.51% | 2,923,910 | $4M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.